While Starton News Today

Healthwell Acquisition Corp. I announced today that it has postponed until further announcement the date of the special meeting of the Company’s stockholders to approve its proposed business...

Healthwell Acquisition Corp. I announced today that it has postponed the date of the special meeting of the Company’s stockholders to approve its proposed business combination with Starton...

Gabrail Cancer & Research Center activated and open to screen patients, with Nash Gabrail, MD as lead investigatorSite activation comes several months ahead of schedule, significantly accelerating Starton’s clinical program timelinePARAMUS, N.J.--(BUSINESS WIRE)--Starton Therapeutics Inc. (“Starton” or “the Company”...

FDA agrees to the planned Phase 1b study in second-line transplant-ineligible patients in multiple myelomaTreatment regimen will include Velcade® (bortezomib) and dexamethasone and replace oral Revlimid® with STAR-LLDPARAMUS, N.J.--(BUSINESS WIRE)--Starton Therapeutics Inc. (“Starton” or “the Company”), a clinical s...

FDA agrees to the planned Phase 1b study in second-line transplant-ineligible patients in multiple myeloma Treatment regimen will include Velcade® and dexamethasone and replace oral... | June 12, 2023

Starton Therapeutics, Inc. , a clinical-stage biotechnology company focused on transforming standard-of-care therapies with proprietary continuous delivery technology, and Healthwell Acquisition... | June 6, 2023